Meta-analysis of LRP1 C766T polymorphism and Alzheimer's disease susceptibility

Exploratory Score: 0.950 Price: $0.50 Alzheimer's disease human patients Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting LRP1 in human patients. Primary outcome: Association between LRP1 C766T polymorphism and AD susceptibility

Description

This meta-analysis examined the association between the LRP1 C766T polymorphism (rs1799986) and Alzheimer's disease susceptibility across multiple populations. The study included 26 independent case-control studies with a total of 6,455 AD cases and 6,304 controls. The analysis investigated overall associations as well as subgroup analyses by ethnicity (Asian vs other populations) and AD onset type (late-onset vs early-onset). Multiple genetic models were tested including allele model (T vs C), dominant model (TT + CT vs CC), and recessive models. The meta-analysis aimed to resolve contradictory findings from previous individual studies regarding this polymorphism's role in AD risk.

TARGET GENE
MODEL SYSTEM
human patients
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
Low-density lipoprotein receptor pathway
SOURCE
extracted_from_pmid_28814781
PRIMARY OUTCOME
Association between LRP1 C766T polymorphism and AD susceptibility

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.950 composite

📖 Wiki Pages

APOE contributes to Alzheimer's disease by regulathypothesisLRP1 GenegeneLRP1-Enhanced Perivascular Drainage TherapyideaLRP1 ProteinproteinLRP1-ApoE Signaling CascadepathwayLRP1-Mediated Amyloid-Beta Clearance in NeurodegenmechanismLRP1-Targeted ApoE-Mimetic Peptide DeliveryideaLRP1 (Low-Density Lipoprotein Receptor-Related ProproteinInvestment Landscape: Alzheimer's DiseasediseasePreclinical Alzheimer's DiseasediseaseProdromal Alzheimer's DiseasediseaseAgitation in Alzheimer's DiseasediseasePSEN2 Mutations in Alzheimer's DiseasediseaseSporadic vs Familial Alzheimer's Disease: ComprehediseaseTREM2 Variants in Alzheimer's Diseasedisease

Protocol

Systematic literature review and meta-analysis of case-control studies. Studies were identified and data extracted for genotype frequencies in AD cases versus controls. Statistical analysis included calculation of odds ratios with 95% confidence intervals for different genetic models. Subgroup analyses were performed by ethnicity and AD onset type.

Expected Outcomes

Clarification of the association between LRP1 C766T polymorphism and AD risk across different populations and AD subtypes

Success Criteria

  • Prespecified primary endpoint (Association between LRP1 C766T polymorphism and AD susceptibility) improves versus control with p < 0.05 or an equivalent corrected threshold used by the study.
  • The effect size is biologically meaningful and reproduced across technical/biological replicates or the validation subset.
  • Safety, data quality, and missingness remain within protocol-defined bounds so the result is interpretable rather than driven by attrition or assay failure.

Related Hypotheses (8)

LRP1-Dependent Tau Uptake Disruption0.808
TREM2-mediated microglial tau clearance enhancement0.618
LRP1-Dependent Tau Uptake Disruption0.600
VCP-Mediated Autophagy Enhancement0.595
Extracellular Vesicle Biogenesis Modulation0.582

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.